Nashville Biosciences
Steven Held began their work experience in 2001 as a Resident in Internal Medicine at UTHSCSA. Steven then served as a Resident in Anatomic and Clinical Pathology at UTHSCSA from 2008 to 2012, during which they were also appointed as Chief Resident for Anatomic and Clinical Pathology. From 2002 to 2010, Steven was a Major in the United States Air Force, where they also served as a Staff Internist from 2004 to 2007. Steven joined the Uniformed Services University of the Health Sciences in 2005 as an Assistant Professor of Medicine until 2007. Steven served as a Pathologist at PathGroup in 2013, followed by being a Clinical Strategist at Concert Genetics from 2014 to 2017. Steven then became a Physician Evaluator at Signify Health in 2014 and later took on the role of Associate Medical Director at Nashville Biosciences in 2019. In the same year, they transitioned to the position of Medical Director at Nashville Biosciences.
Steven Held received a Bachelor of Science (BS) degree in Biology from the University of North Carolina at Chapel Hill, where they studied from 1993 to 1997. Steven then pursued a Doctor of Medicine (M.D.) degree at the University of South Carolina School of Medicine, completing their education from 1997 to 2001.
This person is not in any teams
Nashville Biosciences
Nashville Biosciences, a wholly owned subsidiary of Vanderbilt University Medical Center, was created to harness the medical center's extensive genomic and bioinformatics resources for drug and diagnostics discovery and development. Leveraging Vanderbilt University Innovation™, Nashville Biosciences serves as a commercial interface between outside companies and the formidable research capabilities housed within Vanderbilt University Medical Center, including BioVU®, one of the world’s most comprehensive genetic databases linked to de-identified medical records with years of longitudinal clinical data. This unique asset is one of the largest and highest quality of its kind, providing an unprecedented opportunity to guide R&D activity in biotech, pharma, diagnostics, medical devices and other life sciences applications.